BFO
Boston Family Office Portfolio holdings
AUM $1.51B
1-Year Return
12.61%
This Quarter Return
+4.15%
1 Year Return
+12.61%
3 Year Return
+54.38%
5 Year Return
+90.66%
10 Year Return
+237.26%
AUM
$963M
AUM Growth
+$37.8M
(+4.1%)
Cap. Flow
+$4.3M
Cap. Flow
% of AUM
0.45%
Top 10 Holdings %
Top 10 Hldgs %
22.81%
Holding
263
New
13
Increased
78
Reduced
90
Closed
5
Top Buys
| 1 |
SS&C Technologies
SSNC
|
+$2.17M |
| 2 |
Adobe
ADBE
|
+$1.8M |
| 3 |
JPMorgan Chase
JPM
|
+$1.5M |
| 4 |
Alcon
ALC
|
+$1.43M |
| 5 |
Becton Dickinson
BDX
|
+$924K |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$3.19M |
| 2 |
Air Lease Corp
AL
|
+$2M |
| 3 |
Aflac
AFL
|
+$650K |
| 4 |
DuPont de Nemours
DD
|
+$486K |
| 5 |
Exxon Mobil
XOM
|
+$435K |
Sector Composition
| 1 | Technology | 17.22% |
| 2 | Healthcare | 16.87% |
| 3 | Industrials | 10.43% |
| 4 | Consumer Staples | 8.73% |
| 5 | Financials | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Middleby
MIDD
$6.83B
| $11.4M | 1.18% |
83,721
-142
| -0.2% | -$19.3K |
|
27
Roper Technologies
ROP
$54.1B
| $11.1M | 1.15% |
30,201
-1,071
| -3% | -$392K |
|
28
Stryker
SYK
$144B
| $11M | 1.14% |
53,360
+73
| +0.1% | +$15K |
|
29
Thermo Fisher Scientific
TMO
$182B
| $10.8M | 1.12% |
36,846
+228
| +0.6% | +$67K |
|
30
TE Connectivity
TEL
$62.8B
| $10.4M | 1.08% |
108,458
+6,307
| +6% | +$604K |
|
31
Dollar Tree
DLTR
$19.5B
| $10.2M | 1.06% |
94,920
-1,212
| -1% | -$130K |
|
32
General Mills
GIS
$26.5B
| $9.97M | 1.03% |
189,770
-1,355
| -0.7% | -$71.2K |
|
33
Verizon
VZ
$184B
| $9.72M | 1.01% |
170,168
+40
| +0% | +$2.29K |
|
34
Alphabet (Google) Class C
GOOG
$3.04T
| $9.7M | 1.01% |
179,520
+760
| +0.4% | +$41.1K |
|
|
35
Exxon Mobil
XOM
$489B
| $9.69M | 1.01% |
126,488
-5,670
| -4% | -$435K |
|
36
PepsiCo
PEP
$192B
| $9.53M | 0.99% |
72,673
+83
| +0.1% | +$10.9K |
|
37
NextEra Energy, Inc.
NEE
$144B
| $9.47M | 0.98% |
184,920
+616
| +0.3% | +$31.6K |
|
|
RTN
38
DELISTED
Raytheon Company
RTN
| $9.01M | 0.94% |
51,842
-635
| -1% | -$110K |
|
39
Abbott
ABT
$231B
| $8.83M | 0.92% |
104,945
-1,082
| -1% | -$91K |
|
|
40
Aflac
AFL
$57.6B
| $8.81M | 0.92% |
160,786
-11,859
| -7% | -$650K |
|
41
Merck
MRK
$203B
| $8.14M | 0.85% |
101,726
+95
| +0.1% | +$7.6K |
|
42
McDonald's
MCD
$216B
| $7.74M | 0.8% |
37,279
-42
| -0.1% | -$8.72K |
|
43
Danaher
DHR
$136B
| $7.64M | 0.79% |
60,315
-738
| -1% | -$93.5K |
|
44
Invesco QQQ Trust
QQQ
$374B
| $7.48M | 0.78% |
40,076
-1,683
| -4% | -$314K |
|
45
Idexx Laboratories
IDXX
$51.7B
| $7.26M | 0.75% |
26,357
-135
| -0.5% | -$37.2K |
|
46
Gilead Sciences
GILD
$138B
| $7.15M | 0.74% |
105,845
-868
| -0.8% | -$58.6K |
|
47
CVS Health
CVS
$93.2B
| $6.95M | 0.72% |
127,463
-4,222
| -3% | -$230K |
|
|
48
JPMorgan Chase
JPM
$850B
| $6.52M | 0.68% |
58,341
+13,450
| +30% | +$1.5M |
|
49
S&P Global
SPGI
$165B
| $6.44M | 0.67% |
28,276
-34
| -0.1% | -$7.75K |
|
50
3M
MMM
$83.4B
| $5.85M | 0.61% |
40,360
+110
| +0.3% | +$15.9K |
|